All you need to
design clinical trials
We're on a mission to transform how clinical trials are designed, empowering modern teams to create better studies and bring life-changing therapies to patients faster
From concept to reality
Unify your data
Your HbA1c threshold (≥8.5%) is stricter than 89% of competing Phase 3 trials. Loosening to ≥7% could expand your eligible population by 23%
Optimize your design
The primary objective of this study is to evaluate the efficacy and safety of ARX-247 compared to placebo in adults with Type 2 Diabetes Mellitus.
Secondary objectives include assessment of glycemic control, cardiovascular outcomes, and patient-reported quality of life measures over
Draft with speed
Speed up review cycles
Flag regulatory gaps
Who has helped us so far
Part of NYU's Entrepreneurial Institute, JSprint 2026
Clinical validation partners
Pfizer Start4Health 2025 accelerator
Supporting the initiative against Alzheimer disease
Part of NVIDIA's Inception program
MoU signed for AI-driven clinical trial opportunities
OpenAI for Greece 2026 accelerator
Part of Endeavor's startup ecosystem
Part of NYU's Entrepreneurial Institute, JSprint 2026
Clinical validation partners
Pfizer Start4Health 2025 accelerator
Supporting the initiative against Alzheimer disease
Part of NVIDIA's Inception program
MoU signed for AI-driven clinical trial opportunities
OpenAI for Greece 2026 accelerator
Part of Endeavor's startup ecosystem
Central Knowledge Hub
Teams involved in clinical trial design generate hard-won knowledge with every trial. Most organizations lose this knowledge over time; it gets buried in inboxes, scattered across systems, or lost when people move on
We aim to centralize all that so it is searchable, reusable, and everything stays with your organization. The result is institutional knowledge that compounds instead of disappearing, so every clinical trial your team designs makes the next one stronger
Built for teams designing critical trials
Enterprise Pharma
Accelerate protocol design while reducing costly amendments across global portfolios
Emerging Pharma
Design submission-ready protocols faster, without massive internal infrastructure
CROs
Gain competitive advantage by delivering smarter, faster trials that win sponsor trust
Academia
Build compliant, data-driven protocols for resource-limited teams
Government
Make your region more competitive for global trials, by strengthening your infrastructure